Category Archives: healthcare

The Myth that HCQ Interferes with RDV

It is increasingly clear that on June 15, the FDA executed two coordinated attacks against Hydroxychloroquine (HCQ). One was the EUA revocation, supported by a junk science memo, and a press release saying “the FDA determined that chloroquine and hydroxychloroquine are unlikely to be effective in treating COVID-19 for the authorized uses in the EUA(emphasis is added). The Big Tech and MSM distorted this already incorrect determination by omitting the last clause.

But within hours of this press release, the FDA issued another attack with a scary title Coronavirus (COVID-19) Update: FDA Warns of Newly Discovered Potential Drug Interaction That May Reduce Effectiveness of a COVID-19 Treatment Authorized for Emergency Use. This “update”  started with Continue reading The Myth that HCQ Interferes with RDV

HCQ is Effective and Approved

Hydroxychloroquine (HCQ) is approved by the FDA as an antimalarial and anti-rheumatic medication and can be prescribed by doctors for any disease. Neither the issuance nor the revocation of the Emergency Use Authorization (EUA) for HCQ has any impact on its status as an approved drug available for prescriptions. The EUA was only needed to use HCQ from the Strategic National Stockpile. Continue reading HCQ is Effective and Approved

Yes, there is a cure for COVID-19

The world has a cure for COVID-19. The current COVID-19 mortality in all countries of the Northern Hemisphere, except for Israel, is 4-40 times lower than in the US. Israel stopped using Hydroxychloroquine, probably under the influence of the Big Tech misinformation.

Fig. 1. COVID-19 mortality in the US, Canada, Europe, Asia, Africa, China, and India. Deaths per Million, per day, averaged over 7 days.

Continue reading Yes, there is a cure for COVID-19

The Lancet Doubles Down on anti-HCQ Fraud

2020-08-25 Mehra et al. was worse than fraud.

On August 22, The Lancet published an editorial Trump versus Biden: a fight for the health of a nation, attacking Trump administration and repeating talking points of the Democrat-Socialist party. For example: “The US must move away from a system in which health care is politicised, contentious, and tied to employment, income, and immigration status. In addition, President Trump’s isolationist and anti-scientific adminstration [sic!] has de-prioritised health and health care.” The Lancet is a British journal. This act is an open and in-your-face interference in the American elections.

The British government might re-consider any support it provides to The Lancet. Scientists, regulatory bodies, and the public in both countries should take notice that The Lancet became a political journal, publishing scientific articles matching its politics, and discount them.

On August 21, The Lancet Rheumatology published another anti-HCQ paper, with a surprisingly similar title to the fraudulent  Mehra et al., which was published on May 22 and retracted on June 4.  This new paper is titled: Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study. While it  might not be be an outright fraud, it is incorrect and produced by dubious methods. Continue reading The Lancet Doubles Down on anti-HCQ Fraud

A Study of Actual HCQ Usage is Published in WUWT

Hydroxychloroquine in COVID-19 Treatment, Actual Usage in the USA is published in WUWT. The Supplementary Materials:

Summary.xlsx

Hydroxychloroquine-Actual-Use-USA-Attachment.zip

Based on its results, roughly about 500 thousands Americans were prescribed Hydroxychloroquine for COVID-19 treatment from January through the end of July.

If Hydroxychloroquine were 1/100th as dangerous as fake scientists claim, the media would be choke full of stories about naive citizens, that died from the “Trump touted drug”. Instead, the media regurgitates the story from March 23, when a man died from ingesting fish tank cleaner with chloroquine phosphate. The police suspected that was a murder, but decided to call it an incident.

Same day correction: the rough estimate is changed to ~500,000.

2020-08-25: The Supplementary Materials are uploaded

IDSA against HCQ and Plasma

Two days ago, the Infectious Disease Society (IDSA) published its recommendations against the use of Hydroxychloroquine and convalescent plasma for the treatment of COVID-19. Apparently, they knew that Trump would announce the FDA authorization of plasma therapy for COVID-19, and they wanted to strike  preemptively. At the same time, they recommended the use of the ineffective and unsafe drug, Remdesivir. Continue reading IDSA against HCQ and Plasma

Convalescent Plasma is OK, but HCQ is Better

Convalescent plasma has been widely and successfully used as a COVID-19 treatment. For example, a survey Sermo W3, April 15, shows that 46% of the doctors that had used convalescent plasma or had seen it used, said it is very or extremely effective against COVID-19.

Plasma has been positively mentioned in Hydroxychloroquine-based COVID-19 Treatment, A Systematic Review of Clinical Evidence and Expert Opinion from Physicians’ Surveys.

Continue reading Convalescent Plasma is OK, but HCQ is Better

Oseltamivir and QT Interval

The Brazilian trial, Borba et al. [3], in which critically ill patients were given toxic doses of chloroquine (not hydroxychloroquine), also included oseltamivir. Oseltamivir (Tamiflu®) is known to prolong QT interval [1]. It is also known to cause Bradycardia, both confirmed by animal experiments [2] (citing [1] for the results in humans). The NIH COVID-19 Treatment Guidelines described the Brazilian HCQ trial in detail, but failed to mention that oseltamivir is known to prolong QT interval on its own. The NIH Guidelines also failed to mention that the study authors stressed that the findings cannot be extrapolated to non-severe cases (emphasis is mine): Continue reading Oseltamivir and QT Interval

Multiple Causes of Increase in C19 Cases & Hospitalizations

Update 2020-08-12. A push for more testing might have caused increase in the COVID-19 infection cases, hospitalizations, and deaths. Some doctors require patients with COVID-19 symptoms to have a PCR test before prescribing HCQ-based treatment. More testing caused longer processing times. Consequently, many COVID-19 patients could not receive Hydroxychloroquine-based treatment in time. Some of them ended up in hospitals or even worse. Even patients, who got over it without visible consequences, carried a higher viral load for longer time and spread it wider, compared with those who received HCQ treatment immediately  or after a short wait. Thus, excessive testing was harmful.

The testing numbers were increasing all the time. In the end of June, a push to suddenly increase the demand for PCR tests started, possibly under influence of somebody attempting to overwhelm the existing testing capacities. Continue reading Multiple Causes of Increase in C19 Cases & Hospitalizations

General Masking is Useless

The author has shown that wearing face masks by the public outside of hospital/nursing settings is useless as source control for COVID-19. When mandated, it becomes harmful [1].

Other research has also shown that wearing masks by the public in general is not effective against the spread of a respiratory illness epidemic [2]: “During the 2009 pandemic of H1N1 influenza (swine flu), encouraging the public to wash their hands reduced the incidence of infection significantly whereas wearing facemasks did notContinue reading General Masking is Useless

Why is Critical IT and Communications Infrastructure Insecure?

Google Search, YouTube, Facebook, and Twitter are communications services which have become central part of the critical national infrastructure. These services are owned by Alphabet Inc (GOOG), Facebook Inc. (FB), and Twitter Inc. (TWTR). The federal government gives the critical infrastructure special protection. Currently, the Department of Homeland Security designates sixteen Critical Infrastructure Sectors, because they are vital to the United States. Google Search, YouTube, Facebook, and Twitter appear to fall within two of these designated sectors: Information Technology and Communications. Other sectors include Dams; Defense Industrial Base; Nuclear Reactors, Materials, and Waste. Most of the plants and services in these sectors are owned by private corporations. The ownership does not allow them or their employees to misuse them or to threaten their integrity or functionality. The federal government must secure IT and communications infrastructure and hence must protect Twitter service from abuse by Twitter Inc., its CEO Jack Dorsey, and their woke employees in the same way as it protects nuclear power plants. The same applies to Facebook, YouTube, Google Search, and a few other services, operated by Big Tech. A smooth operation of these services is especially important during the current state of national emergency, declared due to the COVID-19 pandemic. Continue reading Why is Critical IT and Communications Infrastructure Insecure?

Fauci Knew that Remdesivir Ineffective

Dr. Fauci / NIH knew that Remdesivir  was unlikely to be effective for COVID-19, when they promoted it over Hydroxychloroquine.

On April 13, 2020 the paper

Remdesivir with IV Administration Alone is Unlikely to Achieve Adequate Efficacy and Pulmonary Delivery should be Investigated in COVID-19 Patients

by Duxin Sun, PhD was accepted by The AAPS Journal , “An Official Journal of the American Association of Pharmaceutical Scientists” (not related to the great Association of American Physicians and Surgeons). Continue reading Fauci Knew that Remdesivir Ineffective

HCQ, Gilead and MOTU

The aggressive promotion of Remdesivir by Gilead Sciences (GILD) contributed to the campaign against HCQ, the key part of the most effective treatment for C19. Google, Facebook, Twitter, Microsoft, and the fake news media led attacks against HCQ. Gilead Sciences is headquartered in the Silicon Valley.

The following table shows a surprising concentration of publicly traded shares of Gilead, Big Tech / (anti-) social media, and the New York Times in the hands of a small group of 6-8 investment management corporations. Continue reading HCQ, Gilead and MOTU

JAMA Rejected my Comment on Masks and HCQ

JAMA Current  has rejected my comment to a recent peer-reviewed paper, used by the CDC to justify recommendations of universal masking and to downplay the role of hydroxychloroquine in preventing COVID-19 spread. It is well known that health care workers have been taking hydroxychloroquine for COVID-19 prevention, and rightfully so. Such use increased after President Trump mentioned chloroquine derivatives in a March 19 briefing. For example, NPR wrote on March 23: Continue reading JAMA Rejected my Comment on Masks and HCQ

Anti-HCQ Scientific Fraud, Boulware – Skipper, Part 2

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 , Skipper et al., Annals of Internal Medicine, July 16, is fraud.

This a second paper based on the same clinical trial NCT04308668, Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP). David Boulware, MD, was the Chief Investigator. The trial split into two parts: post-exposure prophylaxis (misreported in Boulware et al., NEJM, June 3), and early treatment (misreported in the currently discussed Skipper et al). Boulware and Skipper are among the authors in both papers, so they are referred here as BS-1 and BS-2, respectively. Dr. David Boulware is one of the leading authorities on hydroxychloroquine in COVID-19; the White House medical team asked his advice on COVID-19 prophylaxis. Caleb P Skipper (the guy with no photo) seems to be the designated scapegoat. His name did not appear on scientific papers before 2019. Continue reading Anti-HCQ Scientific Fraud, Boulware – Skipper, Part 2

Google vs HCQ

Google search results for ‘hydroxychloroquine’ include a Knowledge Panel with misinformation:Screenshot of Google search for HCQ with wrong knowledge panel

This knowledge panel features what looks like a scientific description of hydroxychloroquine, except it is fraught with inaccurate information. It attributes to Hydroxychloroquine (HCQ) the properties of an unrelated drug – hydroxyquinoline (HNL). 

Immunosuppressive drug and Anti-parasite

Drug class: Quinoline

Hydroxychloroquine is an Aminoquinoline, not Quinoline! FDA classifies Hydroxychloroquine as antirheumatic and antimalarial, NOT antiparasitic. Continue reading Google vs HCQ